StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) stock

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.46−0.28 (-3.20%)

Close on Nov 17, 2026Market cap $812.52MP/E 11.9Yield –

MeiraGTx price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

MeiraGTx's price to book ratio was 246.8× on Oct 31, 2025, against 4.5× a year earlier. Over the last 5 years it ranged from 2.1× to 246.8×, with a median of 3.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Oct 31, 2025246.8×+241.8
2024Dec 31, 20244.9×+0.4
2023Dec 29, 20234.6×+2.2
2022Dec 30, 20222.4×−3.2
2021Dec 31, 20215.6×+2.4
2020Dec 31, 20203.2×−0.5
2019Dec 31, 20193.8×+1.0
2018Dec 31, 20182.7×–

More MeiraGTx figures

See a number that looks wrong?